MedCity News October 9, 2020
Elise Reuter

When it announced plans to go public through a blank-check company, Clover Health shared ambitious projections for its future membership. Much of that growth is pinned on plans to launch a direct contracting business.

When Clover Health announced its plans to go public via a blank-check company, the insurance startup pitched investors on its growth plans. Its CEO and founder, Vivek Garipalli, claimed it was the fastest growing Medicare Advantage plan over 50,000 lives — based on internal data — and that much of the $1.2 billion in proceeds from the deal would be used to fund its future expansion.

But a closer look shows that much of the San Francisco-based company’s forecasted membership growth hinges on a yet-to-be-launched direct...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare Advantage, Payer, Physician, Primary care, Provider
Medicare Advantage prior authorization: How insurers stack up
Trade groups urge pause on sweeping Medicare Advantage rules
Medicare Advantage in the headlines: 7 recent updates - 7
Where prior authorization stands in 2025
What can hospitals do about Medicare Advantage tensions?

Share This Article